Dow Up0.08% Nasdaq Down0.30%

Cytori Therapeutics, Inc. (CYTX)

-NasdaqGM
1.00 Up 0.06(6.37%) Sep 19, 4:00PM EDT
|After Hours : 0.99 Down 0.01 (1.00%) Sep 19, 5:30PM EDT
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingJun 30, 2014Mar 31, 2014Dec 31, 2013Sep 30, 2013
Total Revenue 1,290   1,434   3,460   2,711  
Cost of Revenue766  421  1,125  931  
Gross Profit 524   1,013   2,335   1,780  
Operating Expenses
Research Development4,674  4,292  5,073  4,123  
Selling General and Administrative6,535  6,268  6,379  6,119  
Non Recurring -   -   -   -  
Others -   -   -   -  
Total Operating Expenses -   -   -   -  
Operating Income or Loss (10,685) (9,547) (9,117) (8,462)
Income from Continuing Operations
Total Other Income/Expenses Net(58)88  17  4,297  
Earnings Before Interest And Taxes(10,743)(9,459)(9,100)(4,165)
Interest Expense1,085  941  940  1,095  
Income Before Tax(11,828)(10,400)(10,040)(5,260)
Income Tax Expense -   -   -   -  
Minority Interest -   -   -   -  
Net Income From Continuing Ops(11,828)(10,400)(10,040)(5,260)
Non-recurring Events
Discontinued Operations -   -   -   -  
Extraordinary Items -   -   -   -  
Effect Of Accounting Changes -   -   -   -  
Other Items -   -   -   -  
Net Income (11,828) (10,400) (10,040) (5,260)
Preferred Stock And Other Adjustments -   -   -   -  
Net Income Applicable To Common Shares (11,828) (10,400) (10,040) (5,260)

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.